Progyny, Inc. reported a record quarterly revenue of $279.4 million, a 43% increase compared to the prior year period. The company achieved a record quarterly operating cash flow of $76.0 million and raised its full-year revenue and earnings guidance, reflecting strong employer demand for fertility and family-building solutions.
Revenue reached $279.4 million, a 43% increase year-over-year, driven by an increase in clients and covered lives.
Fertility benefit services revenue was $172.7 million, a 36% increase from the prior year.
Pharmacy benefit services revenue was $106.6 million, a 56% increase compared to the prior year.
Net cash generated by operating activities was $76.0 million, compared to $19.2 million in the prior year period.
The Company is providing the following financial guidance for the full year ending December 31, 2023 and the three-month period ending September 30, 2023:
Visualization of income flow from segment revenue to net income